Study Reveals Myocardial Dysfunction in Young Adults with Class I Obesity
Research indicates that young adults with Class I obesity exhibit early signs of myocardial dysfunction despite a lack of diagnosed heart disease.
Class I obesity linked to adverse metabolic profiles and impaired myocardial function.
Study involved 131 adults, revealing significant correlations between adipose tissue and heart strain.
Findings suggest a need for early intervention in young adults with mild obesity.
A recent study has uncovered concerning evidence of myocardial dysfunction in young adults classified with Class I obesity, defined by a body mass index (BMI) ranging from 30.0 to 34.9 kg/m². Conducted among 131 participants aged between 21 and 59 years, the research highlights that even in the absence of diagnosed cardiovascular diseases, these individuals display significant impairments in heart function. The findings were presented during a preventive health examination, where participants underwent various assessments including echocardiography and ultrasound evaluation of adipose tissue distribution.
The study revealed that individuals with Class I obesity exhibited a notably adverse metabolic profile, characterized by elevated fasting glucose levels, increased triglycerides, and a higher Visceral Adiposity Index (VAI). Specifically, the group with Class I obesity demonstrated a reduction in left ventricular global longitudinal strain (GLS), a key indicator of heart function, compared to their counterparts with a BMI below 30 kg/m². This reduction in GLS was found to correlate with the thickness of visceral adipose tissue (VAT), suggesting that even mild obesity can lead to early cardiac changes.
Notably, the research indicated that the thickness of epicardial adipose tissue (EAT) was inversely related to left atrial reservoir strain (LASr), further emphasizing the detrimental impact of excess adipose tissue on heart function. These findings challenge the traditional risk assessment methods, which often overlook the specific distribution of adipose tissue and its implications for cardiac health in younger populations.
The implications of this study extend beyond individual health, as obesity is becoming increasingly prevalent across Europe. Current European guidelines emphasize weight management but lack specific tools for identifying individuals at risk of subclinical cardiac involvement due to mild obesity. The study suggests that routine echocardiographic assessments could help identify young adults who may benefit from early intervention, particularly as new anti-obesity treatments become available.
Looking forward, the research raises critical questions about the reversibility of these cardiac changes. While EAT is known to be metabolically active and responsive to weight loss, the extent to which its reduction can restore myocardial function remains uncertain. Future studies are needed to explore whether increased EAT and VAT contribute to the development of hypertension, diabetes, and heart failure, and to establish standardized protocols for assessing these risks in clinical settings.
